American Liver Foundation Statement on FDA Approval of Resmetirom

First drug therapy treatment for nonalcoholic steatohepatitis (NASH) provides hopes to millions of Americans FAIRFIELD, N.J., March 14, 2024 /PRNewswire/ — Today, the Food and Drug Administration (FDA) granted accelerated approval of a first of its kind drug therapy, resmetirom, for the…